About the Academy
Policy Advocacy. Education. Legitimacy & Safety Standards.
Shaping the Future of Peptide Medicine Through Science, Standards, and Advocacy
The American Academy of Peptide Medicine (AAPM) is the official nonprofit academic society dedicated to advancing the responsible clinical use of peptide therapies. We unite physicians, researchers, pharmacists, and policymakers committed to evidence-based practice, rigorous education, and meaningful policy engagement in one of medicine's fastest-growing disciplines.
AAPM operates across three core pillars: policy advocacy to shape fair, science-driven regulation; education and credentialing through the PepMed certification program; and legitimacy and safety standards spanning compounding pharmacy practices, clinician protocols, and patient safety.
Explore Certification
Three Pillars of Impact
Advancing policy advocacy, clinician education, and safety standards
Policy Advocacy
AAPM advocates for fair, science-driven oversight of peptide therapies at the federal and state level, working directly with legislators and regulatory agencies.
- Bipartisan advisory board
- Direct congressional engagement
- Regulatory expertise
Education & Credentialing
Professional development through structured coursework, certification exams, and continuing education partnerships with accredited institutions.
- 5-module curriculum
- Certification exam
- CME/CPE partnerships (planned)
Legitimacy & Safety Standards
Establishing professional standards for peptide medicine through accreditation, quality oversight, and a compliance-first approach across the ecosystem.
- Pharmacy compounding standards
- PCAC partnership
- Compliance-first approach
Founded by Leaders in Medicine and Law
Bridging clinical expertise and regulatory knowledge to build the premier professional society for peptide medicine
Dr. Pradeep Albert, MD
Co-Founder & Chief Medical Officer
A physician leader with deep expertise in regenerative and peptide medicine, Dr. Albert drives AAPM's clinical standards and educational programming.
Lee H. Rosebush
Co-Founder & Chief Pharmacy Officer
A partner at BakerHostetler with extensive regulatory and pharmacy law expertise, Lee leads AAPM's policy advocacy and compliance strategy.
AAPM brings together physicians, researchers, pharmacists, and policymakers under one professional society -- to advance patient access to safe, effective peptide therapies through science-driven standards and bipartisan advocacy.
Join the AcademyReady to Shape the Future of Peptide Medicine?
Join the professional society building the standards, education, and advocacy framework for peptide medicine.